Invention Application
WO2016013829A1 PHARMACEUTICAL COMPOSITION COMPRISING 5ALPHA-REDUCTASE INHIBITOR
审中-公开
包含5ALPHA-REDUCTASE抑制剂的药物组合物
- Patent Title: PHARMACEUTICAL COMPOSITION COMPRISING 5ALPHA-REDUCTASE INHIBITOR
- Patent Title (中): 包含5ALPHA-REDUCTASE抑制剂的药物组合物
-
Application No.: PCT/KR2015/007513Application Date: 2015-07-20
-
Publication No.: WO2016013829A1Publication Date: 2016-01-28
- Inventor: AHN, Byoung Ki , KO, Ki Seong , PARK, So Hyun , KI, Min Hyo , LIM, Jong Lae
- Applicant: CHONG KUN DANG PHARMACEUTICAL CORP.
- Applicant Address: 8, Chungjeong-ro Seodaemun-gu Seoul 120-756 KR
- Assignee: CHONG KUN DANG PHARMACEUTICAL CORP.
- Current Assignee: CHONG KUN DANG PHARMACEUTICAL CORP.
- Current Assignee Address: 8, Chungjeong-ro Seodaemun-gu Seoul 120-756 KR
- Agency: AHN, So Young
- Priority: KR10-2014-0091774 20140721
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K31/473 ; A61K31/573 ; A61K31/216
Abstract:
Disclosed is a composition comprising a 5α-reductase inhibitor. Forming a liquid crystal upon exposure to an aqueous fluid, the composition can release the 5α-reductase inhibitor at a constant rate over a long period of time. In addition, the composition can significantly alleviate irritations attributed to the topical administration of the 5α-reductase inhibitor, and thus the composition has improved safety.
Information query
